BioSpace News Archive

Business

Avita Announces New CFO, Existing CFO Moves to Chief Administrative Officer

Dale will be responsible for overseeing the global finance and investor relations functions, and aligning them with the company’s commercialization strategy.

December 5, 2017

·

5 min read

Business

Agendia Collaborates With Prestigious Cancer Center, Institut Curie, for MammaPrint BluePrint Breast Cancer Kit Co-Validation Study

The co-validation study will demonstrate the performance of this new kit version of the MammaPrint and BluePrint tests in the decentralized setting ahead of the CE-marking and launch of the Kit in Europe early next year.

December 5, 2017

·

5 min read

Miniaturized Surgical Robotic Instruments Expand the Possibilities of Surgical Interventions

The platform allows the surgeon to control two tiny articulated microinstruments that simplify reconstruction procedures after traumatic injuries as well as after tumor removal in soft tissue and bones, and offers the potential for improved surgical success rates and patient outcomes.

December 5, 2017

·

2 min read

CS Genetics Announces Grant of Intellectual Property

CS Genetics Limited, a developer of tools and techniques for genomics, was granted its first patent on 22 November 2017.

December 5, 2017

·

2 min read

Business

Johnson & Johnson Innovation Announces Launch of JLABS @ Shanghai in Collaboration with Shanghai Municipal Government, Pudong New Area Government and Shanghai Pharma Engine Company Ltd

JLABS @ Shanghai will provide resident innovators with a capital efficient and flexible platform including an extensive network that will enable them to accelerate the delivery of life-saving, life-enhancing health and wellness solutions to patients in China and around the world.

December 5, 2017

·

6 min read

Biotech Beach

Ambry Presents Research Expanding Our Understanding of Gene Disease Relationships at the San Antonio Breast Cancer Symposium

Ambry Genetics (Ambry), a leading clinical genetics-testing lab, is presenting data this week at San Antonio Breast Cancer Symposium (SABCS) to help the medical community further understand the genetic mutations behind hereditary breast cancer, which accounts for up to 10% of all breast cancer diagnoses.

December 5, 2017

·

3 min read

GB Sciences Announces Tissue Propagation Breakthrough In Commercial Cannabis Cultivation

GB Sciences explains that 100% of the mother plants in their Las Vegas cultivation facility are now products of the GB Sciences tissue propagation initiative.

December 5, 2017

·

4 min read

Drug Development

Realm Therapeutics Announces First Patient Dosed in Phase II Study of PR022 for the Treatment of Atopic Dermatitis

The Phase 2 study is a randomized, double-blind, vehicle-controlled, multicenter, parallel-group study assessing the safety and efficacy of multiple doses of PR022 in approximately 120 adult patients with mild-to-moderate atopic dermatitis.

December 5, 2017

·

4 min read

Policy

Oncolytics Biotech Receives Favorable Final Advice Letter from the European Medicines Agency for REOLYSIN in Metastatic Breast Cancer

The Letter refers to the proposed use of pelareorep in combination with paclitaxel, for the treatment of hormone receptor positive, HER2 receptor negative metastatic breast cancer patients in a pivotal phase 3 registration study.

December 5, 2017

·

5 min read

Genetown

Verastem to Present Results From Pivotal Phase 3 DUO Study in Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma at a Research and Development Event at ASH 2017

The event will take place on Sunday, December 10, 2017 in Atlanta.

December 5, 2017

·

4 min read